placenta praevia: Abnormal placentation in which the placenta implants in the lower segment of the uterus (the zone of dilation) and may cover part or all of the opening of the cervix. It is often associated with serious antepartum bleeding and premature labor.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1886 |
4. Check minimum number of eventsNone |
1886 |
5. Include endpointsNone |
1886 |
6. Filter based on genotype QC (FinnGen only) |
1886 |
Control definitions (FinnGen only)
- Control exclude
- O15_MATERN_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- O30-O48
- Name in latin
- Placenta praevia
Similar endpoints
↥List of similar endpoints to
Placenta praevia
based on the number of shared cases.
Similar with more cases:
- Maternal care related to the fetus and amniotic cavity and possible delivery problems
- Pregnancy, childbirth and the puerperium
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13295 | 13295 | - |
| Only index persons | 13162 | 13162 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.38 | 0.38 | - |
| Only index persons | 0.48 | 0.48 | - |
| Median age at first event (years) | |||
| Whole population | - | 32.14 | - |
| Only index persons | - | 32.12 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1886 | 1886 | - |
| Unadjusted period prevalence (%) | 0.64 | 0.64 | - |
| Median age at first event (years) | 32.29 | 32.29 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1652
- Matched controls
- 16519
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
22.2
323.0
771
627
O44.0
ICD-10 Finland
Placenta praevia specified as without haemorrhage
+∞
323.0
967
*
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
4522.8
323.0
368
*
O44.1
ICD-10 Finland
Placenta praevia with haemorrhage
+∞
323.0
696
*
O82.0
ICD-10 Finland
Delivery by elective caesarean section
39.4
295.3
377
123
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
21.6
294.2
450
281
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
7.1
256.6
798
1921
O46.9
ICD-10 Finland
Antepartum haemorrhage, unspecified
+∞
210.0
197
*
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
4.8
191.4
1009
4077
O32.1
ICD-10 Finland
Maternal care for breech presentation
691.3
191.0
185
*
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
7.8
170.7
440
737
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
12.0
164.2
319
324
O42.9
ICD-10 Finland
Premature rupture of membranes, unspecified
1755.1
162.2
155
*
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
6.7
162.2
469
919
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
4.5
152.1
718
2430
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
4.4
139.7
655
2161
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
732.5
138.9
135
*
Z39.2
ICD-10 Finland
Routine postpartum follow-up
4.3
126.5
588
1889
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
+∞
124.6
118
*
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
644.3
122.9
120
*
6411A
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Haemorrhage from placenta praevia[PLACENTA PRAEVIA CUM HAEMORRHAGIA,HOITOJ ENNEN SYNN]
+∞
119.2
113
*
SPAT1379
SPAT
Health check-up of pregnant person
4.4
110.3
478
1406
O60
ICD-10 Finland
Preterm labour and delivery
17.7
108.9
175
110
WX320
NOMESCO Finland
Spinalanesthesy
4.4
108.9
474
1398
SPAT1197
SPAT
Extensive health check-up of expecting family
3.8
104.1
539
1848
W78
ICPC
Pregnancy
3.6
101.3
594
2247
SPAT1380
SPAT
Postpartum check-up
4.4
98.1
411
1153
6411B
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Haemorrhage from placenta praevia[PLACENTA PRAEVIA CUM HAEMORRHAGIA,SYNN PÄÄTT HOITOJ]
+∞
96.8
92
*
O48
ICD-10 Finland
Prolonged pregnancy
+∞
95.8
91
*
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
4.6
85.2
335
870
Z32.1
ICD-10 Finland
Pregnancy confirmed
3.8
84.5
419
1349
ZXD05
NOMESCO Finland
Urgent procedure
3.0
83.4
674
3114
O20.0
ICD-10 Finland
Threatened abortion
8.9
81.3
181
224
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
8.3
80.3
188
253
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
4.1
77.8
340
971
O41.0
ICD-10 Finland
Oligohydramnios
761.6
74.8
73
*
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
+∞
74.5
71
*
XMA22
NOMESCO Finland
General examination of pregnant woman
4.6
72.8
281
708
SPAT1196
SPAT
Monitoring of normal pregnancy
4.0
67.6
304
881
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.2
67.0
286
790
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
6.7
65.5
176
288
O42.0
ICD-10 Finland
Premature rupture of membranes, onset of labour within 24 hours
+∞
62.9
60
*
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
3.1
62.4
416
1631
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
3.3
62.3
370
1336
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
3.0
60.3
418
1676
O30.0
ICD-10 Finland
Twin pregnancy
+∞
59.7
57
*
8811
FHL
Cesarean section
5.0
58.9
204
454
O32.2
ICD-10 Finland
Maternal care for transverse and oblique lie
588.0
58.0
57
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.6
57.0
292
935
MAA00
NOMESCO Finland
Amniocentesis
13.0
56.6
102
83
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
+∞
54.5
52
*
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
534.5
52.8
52
*
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
11.4
52.6
101
94
6410A
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Placenta praevia without haemorrhage[PLACENTA PRAEVIA SINE HAEMORRH,HOITOJ ENNEN SYNN]
+∞
51.3
49
*
O80.0
ICD-10 Finland
Spontaneous vertex delivery
2.2
49.7
869
5574
W84
ICPC
Pregnancy high risk
5.6
48.4
149
288
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
5.6
48.4
148
284
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
2.5
47.0
452
2159
O40
ICD-10 Finland
Polyhydramnios
+∞
45.0
43
*
O46.8
ICD-10 Finland
Other antepartum haemorrhage
+∞
43.9
42
*
W92
ICPC
Compl labour/ delivery livebirth
7.8
43.0
102
138
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
3.9
41.1
181
503
O02.1
ICD-10 Finland
Missed abortion
3.3
40.9
226
754
6410B
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Placenta praevia without haemorrhage[PLACENTA PRAEVIA SINE HAEMORRHAGIA,SYNN PÄÄT HOITOJ]
+∞
40.8
39
*
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
+∞
38.7
37
*
O41.1
ICD-10 Finland
Infection of amniotic sac and membranes
+∞
38.7
37
*
WX307
NOMESCO Finland
Obstetric epidural analgesia
2.8
38.3
283
1147
O80.8
ICD-10 Finland
Other single spontaneous delivery
4.5
37.6
140
332
Z37.0
ICD-10 Finland
Single live birth
2.4
37.4
377
1812
O36.9
ICD-10 Finland
Maternal care for fetal problem, unspecified
+∞
36.6
35
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.9
36.6
812
5476
G03GA01
ATC
chorionic gonadotrophin; parenteral
3.3
36.5
197
645
O47.9
ICD-10 Finland
False labour, unspecified
18.7
36.4
56
31
O42.1
ICD-10 Finland
Premature rupture of membranes, onset of labour after 24 hours
+∞
35.5
34
*
MAB20
NOMESCO Finland
Failed external version
126.1
34.8
37
*
O99.80
ICD-10 Finland
The fear of childbirth
3.6
34.7
170
515
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
2.5
33.5
289
1273
O72.0
ICD-10 Finland
Third-stage haemorrhage
5.0
32.5
109
232
MAX99
NOMESCO Finland
Assistance to normal delivery
2.3
32.0
331
1599
O34.1
ICD-10 Finland
Maternal care for tumour of corpus uteri
+∞
31.3
30
*
W85
ICPC
Gestational diabetes
3.7
31.0
143
412
ZXE00
NOMESCO Finland
One hour or less
1.9
29.6
671
4442
N97.9
ICD-10 Finland
Female infertility, unspecified
2.6
29.0
242
1041
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
3.3
29.0
156
507
O72.2
ICD-10 Finland
Delayed and secondary postpartum haemorrhage
6.0
28.5
80
138
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
28.2
537
3327
G03GA06
ATC
follitropin beta; parenteral
3.7
28.0
128
366
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
3.7
27.1
126
365
SPAT1357
SPAT
Monitoring of problem during pregnancy
4.3
26.9
104
256
W90
ICPC
Uncompl labour/delivery livebirth
3.3
26.9
143
461
H01CA02
ATC
nafarelin; nasal
3.4
25.7
133
420
MA3AE
NOMESCO Finland
Combined first trimester screening
3.1
25.6
147
501
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
3.0
24.1
147
519
G03GA05
ATC
follitropin alfa; parenteral
3.1
23.8
135
455
MAB10
NOMESCO Finland
External version
88.1
23.7
26
*
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
2.9
23.6
150
547
LGA20
NOMESCO Finland
Sterilisation by constriction of Fallopian tubes
10.0
23.1
46
47
6441A
ICD-9 Finland
Early or threatened labour, Other threatened labour
+∞
23.0
22
*
O45.9
ICD-10 Finland
Premature separation of placenta, unspecified
+∞
23.0
22
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
5.8
22.9
66
118
O64.1
ICD-10 Finland
Obstructed labour due to breech presentation
13.7
22.8
39
29
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.0
22.5
341
1915
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
2.9
22.3
144
530
O72.1
ICD-10 Finland
Other immediate postpartum haemorrhage
4.0
22.3
92
241
Z3232
NOMESCO Finland
Midwife
2.1
22.2
301
1614
Z35.4
ICD-10 Finland
Supervision of pregnancy with grand multiparity
12.9
22.2
39
31
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.8
22.0
75
163
G03DA04
ATC
progesterone; systemic, rectal, vaginal
3.4
21.9
112
350
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
6.7
21.4
55
85
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
3.1
21.3
122
414
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
4.5
21.3
77
178
SPAT1189
SPAT
Other ultrasound examination during pregnancy
3.5
21.1
102
305
MAC96
NOMESCO Finland
Other induction or advancement of labour
4.0
20.8
85
221
SPAT1200
SPAT
Guidance for breast-feeding and breast care
3.7
20.1
89
248
MA4AT
NOMESCO Finland
Chorion biopsy with ultrasound guidance
58.3
19.9
23
*
O36.3
ICD-10 Finland
Maternal care for signs of fetal hypoxia
+∞
19.8
19
*
N97.8
ICD-10 Finland
Female infertility of other origin
3.4
19.8
100
310
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
19.8
564
3879
O84.2
ICD-10 Finland
Multiple delivery, all by caesarean section
202.3
19.6
20
*
LGA10
NOMESCO Finland
Sterilisation by destruction or division of Fallopian tubes
9.7
19.4
39
41
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
3.1
19.1
110
375
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
10.2
18.9
37
37
O34.3
ICD-10 Finland
Maternal care for cervical incompetence
+∞
18.8
18
*
O82.11
ICD-10 Finland
Childbirth with an emergency caesarean section in an emergency
7.5
18.7
44
60
MBA30
NOMESCO Finland
Manual removal of placenta from delivered uterus
4.3
18.3
68
162
Z39.1
ICD-10 Finland
Care and examination of lactating mother
4.2
18.2
69
168
Z34
ICD-10 Finland
Supervision of normal pregnancy
2.5
18.2
150
637
FM1QE
NOMESCO Finland
Extensive ultrasound of fetal heart
11.6
18.0
33
29
N80.1
ICD-10 Finland
Endometriosis of ovary
2.6
18.0
137
557
LAA10
NOMESCO Finland
Percutaneous or transvaginal puncture and recovery of oocyte
3.0
17.9
107
372
O20.8
ICD-10 Finland
Other haemorrhage in early pregnancy
9.7
17.9
36
38
H01CC01
ATC
ganirelix; parenteral
2.9
17.7
111
400
SPAT1263
SPAT
Sampling
1.6
17.7
646
4718
MBB10
NOMESCO Finland
Packing of delivered uterus
37.1
17.6
22
6
TLW10
NOMESCO Finland
Transfer of fresh embryo
3.5
17.1
80
234
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
4.4
16.9
61
142
Z30.2
ICD-10 Finland
Sterilization
1.9
16.8
254
1411
6418A
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Other antepartum haemorrhage[ALIA HAEMORRHAGIA IN GRAVIDITATE,HOITOJ ENNEN SYNN]
+∞
16.7
16
*
L02AE02
ATC
leuprorelin; implant, parenteral
3.8
16.6
72
198
SPAT1373
SPAT
Combined screening in early pregnancy
4.8
16.6
55
117
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.9
16.5
290
1700
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
2.5
16.5
130
538
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
4.2
16.5
63
155
SPAT1375
SPAT
Structural ultrasound screening, weeks 18+0-21+6
7.1
16.1
39
56
6440B
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]
6.3
16.0
42
68
MAC01
NOMESCO Finland
Rupture of aminiotic membrane for induction of labor
4.9
16.0
52
109
ZXD00
NOMESCO Finland
Emergency procedure
3.8
15.6
67
183
MBA05
NOMESCO Finland
Curettage of uterus after abortion
5.3
15.3
46
88
MBA96
NOMESCO Finland
Other removal of retained products of conception after delivery or abortion
3.4
15.3
76
234
O03.1
ICD-10 Finland
Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage
4.2
15.2
58
143
MAC40
NOMESCO Finland
Pharmacological induction or advancement of labor
4.7
15.0
50
108
O03.4
ICD-10 Finland
Spontaneous abortion, Incomplete, without complication
3.2
14.9
79
255
O61.0
ICD-10 Finland
Failed medical induction of labour
7.1
14.9
36
52
TLW12
NOMESCO Finland
Insertion of frozen embryo
3.4
14.8
72
218
Z36.8
ICD-10 Finland
Other antenatal screening
3.4
14.8
72
219
MBA00
NOMESCO Finland
Vacuum aspiration from uterus after delivery or abortion
3.2
14.6
77
248
6419A
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Unspecified antepartum haemorrhage[HAEMORRHAGIA NUD IN GRAVIDITATE,HOITOJ ENN SYNN NUD]
+∞
14.6
14
*
W29
ICPC
Pregnancy symptom/complaint other
3.2
14.5
75
239
J01DB01
ATC
cefalexin; oral
1.6
14.3
1317
11707
Z39.0
ICD-10 Finland
Care and examination immediately after delivery
5.7
14.1
40
72
LBF01
NOMESCO Finland
Laparoscopic perfusion of Fallopian tube
3.4
13.9
66
197
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
13.8
486
3462
O63.0
ICD-10 Finland
Prolonged first stage (of labour)
4.3
13.8
50
118
O34.8
ICD-10 Finland
Maternal care for other abnormalities of pelvic organs
+∞
13.6
13
*
O43.2
ICD-10 Finland
Morbidly adherent placenta
+∞
13.6
13
*
6412B
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Premature separation of placenta[ABLATIO PLACENTAE ANTETEMPUS,SYNN PÄÄTT HOITOJAKSO]
+∞
13.6
13
*
Z35.1
ICD-10 Finland
Supervision of pregnancy with history of abortive outcome
11.0
13.5
25
23
O85
ICD-10 Finland
Puerperal sepsis
5.7
13.5
38
68
O21.0
ICD-10 Finland
Mild hyperemesis gravidarum
5.2
13.2
40
78
O73.1
ICD-10 Finland
Retained portions of placenta and membranes, without haemorrhage
5.6
13.0
37
67
P01AB01
ATC
metronidazole; oral, rectal
1.5
12.9
680
5289
W03
ICPC
Antepartum bleeding
5.9
12.9
35
60
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
2.3
12.8
121
550
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.8
12.8
245
1469
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
2.1
12.8
151
758
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
5.5
12.7
37
69
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
12.7
596
4521
G03GA02
ATC
human menopausal gonadotrophin; parenteral
2.6
12.5
90
355
O45.8
ICD-10 Finland
Other premature separation of placenta
+∞
12.5
12
*
O36.4
ICD-10 Finland
Maternal care for intrauterine death
+∞
12.5
12
*
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
3.6
12.5
55
155
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
5.1
12.3
38
76
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
3.7
12.2
52
143
Z32.0
ICD-10 Finland
Pregnancy, not (yet) confirmed
2.8
12.2
79
292
FM1NE
NOMESCO Finland
Ultrasound examination of fetal heart
26.9
12.0
16
6
XLA10
NOMESCO Finland
NA
2.3
12.0
110
491
B01AB05
ATC
enoxaparin; parenteral
1.6
12.0
335
2240
L02AE01
ATC
buserelin; implant, nasal, parenteral
4.0
11.9
47
121
O28.3
ICD-10 Finland
Abnormal ultrasonic finding on antenatal screening of mother
8.4
11.8
25
30
O81.4
ICD-10 Finland
Vacuum extractor delivery
1.9
11.6
167
909
O44
ICD-10 Finland
Placenta praevia
+∞
11.5
11
*
O43.8
ICD-10 Finland
Other placental disorders
+∞
11.5
11
*
O30.00
ICD-10 Finland
Twin pregnancy with separate amniotic and chorionic sacs
+∞
11.5
11
*
N97.1
ICD-10 Finland
Female infertility of tubal origin
3.8
11.3
46
122
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
4.2
11.2
42
103
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
3.4
11.2
53
159
R2110
NOMESCO Finland
Giving the first information
2.0
11.2
144
751
WX322
NOMESCO Finland
Combined spinal-epidural analgesia in obstetrics
3.0
11.0
61
206
N02BE01
ATC
paracetamol; systemic, rectal
1.5
11.0
1323
11974
PC7NT
NOMESCO Finland
Endovascular occlusion of uteral arteries to stop puerperal bleeding
43.6
10.9
13
*
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.0
10.9
141
736
O84.0
ICD-10 Finland
Multiple delivery, all spontaneous
28.2
10.7
14
5
O26.7
ICD-10 Finland
Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium
5.0
10.7
33
67
G02CB01
ATC
bromocriptine; systemic
3.3
10.5
51
157
A02BC01
ATC
omeprazole; systemic
1.6
10.4
324
2221
N80.9
ICD-10 Finland
Endometriosis, unspecified
2.5
10.3
80
332
G03GB02
ATC
clomifene; oral
2.8
10.2
64
234
W27
ICPC
Fear of complications of pregnancy
4.5
10.1
34
76
J01DA01
ATC
[U] cefalexin; systemic
1.4
9.9
987
8508
Z36.4
ICD-10 Finland
Antenatal screening for fetal growth retardation using ultrasound and other physical methods
3.3
9.7
48
150
SPAT1315
SPAT
Periodic health check-up of children and adolescents
2.5
9.7
76
317
O86.1
ICD-10 Finland
Other infection of genital tract following delivery
5.9
9.7
26
45
O73.0
ICD-10 Finland
Retained placenta without haemorrhage
4.8
9.7
31
66
Z39
ICD-10 Finland
Postpartum care and examination
3.9
9.5
38
100
NE1AG
NOMESCO Finland
MRI pelvimetry with high intensity magnet
100.6
9.4
10
*
6510B
ICD-9 Finland
Multiple gestation, Twin pregnancy[GEMINI, SYNNYTYKSEN AIKANA]
+∞
9.4
9
*
MA2BG
NOMESCO Finland
Fetal examination with high intensity magnet
+∞
9.4
9
*
O32.0
ICD-10 Finland
Maternal care for unstable lie
+∞
9.4
9
*
6581A
ICD-9 Finland
Other problems associated with amniotic cavity and membranes, Premature rupture of membranes
+∞
9.4
9
*
MCA30
NOMESCO Finland
Supravaginal caesarean hysterectomy
+∞
9.4
9
*
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
4.9
9.3
29
60
O86.0
ICD-10 Finland
Infection of obstetric surgical wound
4.9
9.3
29
60
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
4.2
9.3
34
83
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
9.2
572
4512
LA2AE
NOMESCO Finland
Ultrasound examination of ovarian cyst
2.4
9.1
76
328
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
9.1
91
427
O23.1
ICD-10 Finland
Infections of bladder in pregnancy
11.5
9.1
16
14
6440A
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS IMMINENS]
3.4
8.9
42
127
O75.7
ICD-10 Finland
Vaginal delivery following previous caesarean section
24.1
8.9
12
5
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
3.5
8.9
40
117
C08CA05
ATC
nifedipine; systemic
2.6
8.9
62
244
OAA12
SPAT
NA
3.2
8.8
44
139
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
2.3
8.7
81
370
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
4.7
8.4
27
58
O69.4
ICD-10 Finland
Labour and delivery complicated by vasa praevia
+∞
8.3
8
*
O43.9
ICD-10 Finland
Placental disorder, unspecified
+∞
8.3
8
*
O35.2
ICD-10 Finland
Maternal care for (suspected) hereditary disease in fetus
+∞
8.3
8
*
A05AA02
ATC
ursodeoxycholic acid; oral
3.4
8.3
38
113
LAA06
NOMESCO Finland
Transvaginal puncture of ovarian cyst
4.2
8.3
30
73
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
2.8
8.3
50
181
MAE00
NOMESCO Finland
Outlet vacuum delivery
1.8
8.2
137
784
TLW00
NOMESCO Finland
Insemination
2.5
8.2
63
260
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.2
8.1
40
126
MCA00
NOMESCO Finland
Upper uterine segment caesarean section
33.5
8.1
10
*
OAA11
SPAT
NA
2.4
8.0
66
284
MBA04
NOMESCO Finland
Curettage of uterus after delivery
4.6
8.0
26
57
SGA01
NOMESCO Finland
Tooth opening as first aid
1.5
7.9
274
1914
O80.1
ICD-10 Finland
Spontaneous breech delivery
7.8
7.9
17
22
O47
ICD-10 Finland
False labour
5.4
7.8
22
41
N80.89
ICD-10 Finland
Endometriosis with other specified or multiple localization
4.3
7.7
27
64
J01CA08
ATC
pivmecillinam; oral
1.3
7.7
781
6627
O14.1
ICD-10 Finland
Severe pre-eclampsia
4.1
7.6
28
70
Z36.2
ICD-10 Finland
Other antenatal screening based on amniocentesis
10.1
7.5
14
14
Z2221
NOMESCO Finland
Medical doctor
1.4
7.5
445
3456
MBA40
NOMESCO Finland
Pharmacological evacuation of uterus after abortion
2.8
7.5
46
169
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.0
7.5
41
140
O64.0
ICD-10 Finland
Obstructed labour due to incomplete rotation of fetal head
2.7
7.4
48
182
SPAT1190
SPAT
Insertion or removal of intrauterine contraceptive device
1.7
7.3
166
1043
O41.9
ICD-10 Finland
Disorder of amniotic fluid and membranes, unspecified
+∞
7.3
7
*
6510A
ICD-9 Finland
Multiple gestation, Twin pregnancy[GEMINI, RASKAUDEN AIKANA]
+∞
7.3
7
*
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
+∞
7.3
7
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
7.2
60
259
B02AA02
ATC
tranexamic acid; systemic
1.5
7.2
302
2196
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.0
7.2
93
489
WX600
NOMESCO Finland
Single shot through catheter
2.8
7.1
42
150
6523B
ICD-9 Finland
Malposition and malpresentation of foetus, Transverse or oblique presentation[SITUS TRANSVERSUS ET OBLIQUUS,SYNNYTYKSEN AIKANA]
20.1
7.1
10
5
SPAT1192
SPAT
Gynaecological examination
1.5
7.1
261
1844
SPAT1195
SPAT
Antenatal classes
2.1
7.1
79
391
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
7.1
303
2214
SPAT1316
SPAT
Extensive health check-up of children and adolescents
2.3
7.0
64
288
Z31.2
ICD-10 Finland
In vitrofertilization
3.7
7.0
28
76
WW500
NOMESCO Finland
Blood transfusion
2.6
7.0
46
177
6671A
ICD-9 Finland
Retained placenta or membranes, without haemorrhage, Retained portions of placenta or membranes, without haemorrhage
6.3
6.9
17
27
SPAT1303
SPAT
Counselling and guidance related to growth and development
4.3
6.9
24
57
TMW99
NOMESCO Finland
Other minor surgical procedure in obstetrics
4.6
6.9
22
48
JAH01
NOMESCO Finland
Laparoscopy
1.9
6.9
93
498
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
6.9
127
752
ULC02
NOMESCO Finland
Hysteroscopy
1.9
6.9
96
518
LAC01
NOMESCO Finland
Laparoscopic excision of ovarian cyst
2.4
6.8
55
235
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.6
6.8
170
1099
O21
ICD-10 Finland
Excessive vomiting in pregnancy
4.5
6.8
22
49
MAW96
NOMESCO Finland
Other operation in pregnancy or at delivery
5.3
6.8
19
36
O34.4
ICD-10 Finland
Maternal care for other abnormalities of cervix
40.2
6.8
8
*
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
3.9
6.7
25
64
SPAT1382
SPAT
Extensive health check-up at 18 months of age
4.9
6.7
20
41
XMA20
NOMESCO Finland
Early examination of pregnancy
3.0
6.7
36
123
N80.4
ICD-10 Finland
Endometriosis of rectovaginal septum and vagina
2.5
6.6
50
207
O70.2
ICD-10 Finland
Third degree perineal laceration during delivery
4.0
6.6
24
60
N83.1
ICD-10 Finland
Corpus luteum cyst
2.8
6.5
39
142
Z32
ICD-10 Finland
Pregnancy examination and test
3.5
6.5
28
81
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
3.3
6.5
30
92
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
6.5
478
3835
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
6.4
1509
14395
N05AH02
ATC
clozapine; systemic
0.1
6.4
*
191
W05
ICPC
Pregnancy vomiting/nausea
4.1
6.4
23
57
N99.4
ICD-10 Finland
Postprocedural pelvic peritoneal adhesions
4.0
6.3
23
58
6400A
ICD-9 Finland
Haemorrhage in early pregnancy, Threatened abortion
3.7
6.3
25
68
O71.0
ICD-10 Finland
Rupture of uterus before onset of labour
+∞
6.3
6
*
O91.2
ICD-10 Finland
Nonpurulent mastitis associated with childbirth
3.2
6.2
30
96
O63.1
ICD-10 Finland
Prolonged second stage (of labour)
2.0
6.1
72
365
MBC10
NOMESCO Finland
Repair of obstetric laceration of vagina
2.7
6.1
40
153
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
6.1
941
8355
SPAT1383
SPAT
Extensive health check-up at 4 years of age
3.7
6.1
24
65
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
461
1682
3.30
97.94
1.6
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
230
651
3.88
70.88
1.7
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
613
3147
2.40
63.86
1.7
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
211
606
3.79
63.46
1.8
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
306
1127
3.05
61.80
1.5
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
275
1079
2.81
48.86
1.6
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
675
3974
2.09
47.47
2.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
251
973
2.82
45.47
1.5
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
250
973
2.81
44.93
1.5
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
251
981
2.80
44.74
1.5
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
251
982
2.79
44.65
1.5
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
164
511
3.42
43.22
1.5
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
113
315
3.75
35.14
2.3
2.1
umol/l
4.7
6.1
0.49
86
239
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
387
2051
2.12
34.39
2.2
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
954
6998
1.74
29.65
4.6
3.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
83
214
4.01
28.80
1.8
1.4
mmol/l
6.9
7.7
2.11
51
122
(3031040) Bacteria [#/volume] in Urine by Automated count
1229
9738
1.75
28.39
4.1
3.5
e6/l
218.9
1096.6
—
7
98
(3029396) Erythrocyte agglutination [Presence] in Blood
41
57
7.33
28.03
3.8
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
198
906
2.32
24.84
1.5
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
203
941
2.30
24.70
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
197
915
2.29
23.84
1.5
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
726
5201
1.64
22.73
2.1
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1252
10287
1.65
22.14
3.8
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
606
4342
1.58
17.95
2.2
1.9
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
47
132
3.63
14.53
1.1
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
511
3692
1.53
13.92
2.1
2.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
270
1691
1.70
13.30
2.5
2.0
u/l
5263.7
4920.8
0.09
144
619
(3003694) ABO and Rh group [Type] in Blood
657
5052
1.46
12.98
2.1
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
62
228
2.78
12.31
1.6
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
869
7102
1.41
12.04
3.8
3.7
mmol/l
6.0
6.2
4.19
765
6531
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
447
3243
1.50
11.63
2.1
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
99
482
2.11
10.64
1.2
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
35
105
3.38
9.87
1.5
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
882
7462
1.34
8.85
3.1
3.0
estimate
0.0
0.0
0.50
185
1378
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
30
90
3.37
8.49
1.5
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
202
0.00
8.10
0.0
19.4
—
6318.3
—
0
193
(40761511) CBC panel - Blood by Automated count
1782
17062
1.81
7.99
9.6
8.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
883
7547
1.32
7.95
3.3
3.0
estimate
0.0
0.0
0.12
192
1401
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
31
100
3.14
7.84
1.5
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
871
7486
1.30
7.31
4.4
4.2
estimate
0.0
0.0
0.80
195
1440
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
599
4915
1.32
6.97
1.8
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
58
272
2.17
6.96
1.8
1.4
mmol/l
6.1
7.3
3.02
38
198
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
694
5883
1.28
6.15
3.2
2.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
472
3804
1.32
6.11
3.4
3.2
estimate
0.0
0.0
1.34
196
1422
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
370
2893
1.35
5.87
1.7
1.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
195
1365
1.48
5.85
2.4
2.3
u/ml
34.0
33.5
0.03
186
1322
(3019150) Specific gravity of Urine by Refractometry
384
3041
1.33
5.57
3.4
3.1
kg/l
1.0
1.0
0.06
60
406
(40761536) Microorganisms panel - Urine sediment
178
1240
1.48
5.48
3.3
3.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1505
14152
1.31
5.28
11.7
11.8
%
13.4
13.5
1.52
1476
13898
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1670
15956
1.41
5.24
9.9
9.6
mg/l
19.5
18.2
0.91
1348
11966
(3026782) Osmolality of Urine
296
2278
1.36
5.18
2.3
2.4
mosm/kgh2o
531.8
527.3
0.11
263
1944
(3023103) Potassium [Moles/volume] in Serum or Plasma
1592
15110
1.34
5.08
8.1
8.9
mmol/l
3.9
3.9
0.51
1559
14662
(3018738) Hemoglobin F/Hemoglobin.total in Blood
8
6
13.38
5.08
1.3
1.0
%
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1538
14527
1.32
5.07
4.2
3.8
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
38
173
2.22
4.98
1.7
1.4
mmol/l
12.3
13.2
—
5
28
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
61
334
1.85
4.86
1.2
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1585
15066
1.33
4.76
8.0
8.9
mmol/l
139.4
139.5
0.99
1556
14657
(3018095) Leukocytes [#/volume] in Urine
556
4725
1.25
4.54
3.0
3.1
e6/l
59.6
49.4
0.15
369
2995
(3041096) Erythrocytes [Presence] in Urine by Automated
524
4430
1.25
4.46
2.7
2.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1008
9156
1.22
4.26
3.1
2.9
ug/l
71.2
63.5
0.37
967
8786
(3000850) Epithelial cells [#/volume] in Urine
311
2482
1.30
4.21
2.1
2.2
e6/l
7.2
9.1
1.28
260
2158
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
475
4006
1.25
4.09
2.5
2.5
u/l
52.6
53.8
0.53
443
3752
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
78
493
1.61
3.80
1.6
2.0
%
91.5
96.3
1.05
72
457
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
620
5430
1.21
3.65
1.5
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
386
3221
1.25
3.61
1.3
1.3
u/ml
8.9
10.0
0.12
155
1406
(3036489) Thrombin time
84
548
1.56
3.60
1.6
2.0
s
19.9
20.7
1.08
69
458
(3032080) INR in Blood by Coagulation assay
438
3709
1.24
3.59
5.0
4.8
inr
1.1
1.1
0.71
150
1272
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
92
614
1.52
3.56
1.4
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
395
3316
1.24
3.50
2.5
2.6
e6/l
0.2
0.3
0.30
302
2405
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
41
222
1.87
3.47
2.7
2.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
79
513
1.56
3.46
2.3
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
418
3543
1.23
3.38
1.8
1.7
mg/l
1.2
0.7
2.52
305
2621
(3002582) Erythrocytes [#/volume] in Urine
425
3610
1.23
3.36
2.6
2.7
e6/l
31.4
80.0
1.20
327
2681
(3014051) Protein [Presence] in Urine by Test strip
49
284
1.74
3.34
1.6
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
92
626
1.49
3.28
1.1
1.1
u/ml
2.1
3.0
0.38
15
118
(3029612) Listeria sp Ab [Titer] in Serum
6
7
8.59
3.26
1.3
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
24
109
2.22
3.26
1.9
2.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
1850
18216
1.82
3.23
14.8
14.5
pg
29.9
30.0
0.60
1841
18067
(3024731) MCV [Entitic volume]
1850
18217
1.81
3.21
14.8
14.5
fl
89.8
90.0
1.93
1841
18070
(3026361) Erythrocytes [#/volume] in Blood
1850
18220
1.81
3.16
14.8
14.6
e12/l
4.4
4.5
5.24
1828
17874
(3011397) Hemoglobin [Presence] in Urine by Test strip
392
3323
1.23
3.15
3.0
3.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
80
0.00
3.14
0.0
2.1
—
168.5
—
0
68
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
73
2.48
3.13
1.2
1.1
%
107.7
88.6
—
10
22
(3010813) Leukocytes [#/volume] in Blood
1850
18224
1.79
3.10
14.9
14.6
e9/l
6.9
6.6
3.92
1826
17854
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
38
209
1.84
3.09
1.4
1.3
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
74
2.45
3.05
1.2
1.0
%
102.6
90.4
—
10
23
(3000963) Hemoglobin [Mass/volume] in Blood
1850
18229
1.78
3.02
14.9
14.6
g/l
132.1
133.6
8.06
1842
18076
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
5
5
10.02
2.98
1.2
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
54
333
1.64
2.97
2.2
3.2
g/l
0.6
0.4
0.19
14
136
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
357
3018
1.23
2.94
1.5
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
435
3757
1.21
2.88
2.2
2.4
ng/l
20.3
25.0
0.24
132
1400
(3007461) Platelets [#/volume] in Blood
1847
18201
1.71
2.87
14.8
14.6
e9/l
266.7
274.6
6.90
1823
17870
(3045414) Leukocytes [Presence] in Urine
89
620
1.46
2.86
1.5
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
391
3348
1.21
2.83
2.5
2.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
15
59
2.55
2.79
2.5
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
66
437
1.53
2.72
7.5
8.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
292
2439
1.23
2.70
3.0
3.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
51
319
1.62
2.68
1.3
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
24
3.76
2.67
1.0
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
51
322
1.60
2.59
1.3
1.3
u/ml
19.8
23.9
—
5
10
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
60
394
1.54
2.58
1.6
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
115
856
1.37
2.57
2.8
2.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
5
7
7.16
2.55
7.4
9.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
193
1548
1.27
2.54
1.5
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
26
136
1.92
2.51
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
221
1807
1.25
2.48
2.4
2.8
ng/l
94.0
347.8
1.85
96
842
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
48
304
1.59
2.43
1.3
1.4
u/ml
101.3
114.3
0.83
17
64
(3052851) Hemolysis interference index of Serum or Plasma
57
376
1.53
2.42
1.9
2.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
12
46
2.62
2.36
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
387
3366
1.19
2.35
1.3
1.3
iu/ml
18.7
22.6
0.54
121
1035
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
190
1538
1.26
2.34
1.6
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
489
4340
1.17
2.33
2.2
2.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
15
65
2.32
2.31
1.1
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
6
13
4.63
2.27
1.7
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
14
4.30
2.15
1.7
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
19
3.69
2.15
1.3
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
71
505
1.42
2.11
2.4
2.2
iu/l
4.2
3.8
0.20
33
236
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
400
3520
1.17
2.11
1.9
2.1
mg/l
2.4
2.7
2.45
362
3050
(4211845)
15
69
2.18
2.04
2.6
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
612
6690
0.87
2.02
2.2
2.3
nmol/l
73.1
73.6
0.20
578
6354
(3023511) Choriogonadotropin [Units/volume] in Urine
126
990
1.29
2.00
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
313
2714
1.18
1.97
1.7
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
764
8205
0.88
1.88
5.0
6.3
e9/l
0.2
0.2
0.33
691
7433
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
62
444
1.41
1.82
1.4
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
66
2.13
1.82
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
217
1835
1.21
1.81
2.1
2.4
e6/l
4.6
4.9
0.10
123
910
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1576
15329
1.17
1.79
5.1
4.9
mu/l
1.6
2.0
1.89
1515
14702
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
263
2270
1.18
1.76
1.5
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
64
466
1.39
1.72
4.7
4.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1416
13684
1.14
1.69
4.5
4.3
pmol/l
14.2
14.2
0.19
1347
12988
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
174
1452
1.22
1.68
3.1
3.4
pmol/l
4.6
4.5
0.46
158
1305
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
358
3185
1.15
1.64
1.6
2.0
u/l
142.5
147.2
0.06
349
3035
(4024509)
17
91
1.88
1.60
1.1
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
15
77
1.96
1.59
1.5
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
53
381
1.40
1.56
1.1
1.0
u/ml
1.5
2.1
0.75
27
226
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
53
381
1.40
1.56
1.8
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
114
919
1.26
1.53
7.2
6.7
mmol/l
0.3
0.8
0.82
90
686
(3002256) Pathology report gross observation
236
2045
1.18
1.53
1.2
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
743
7921
0.90
1.51
4.9
5.9
e9/l
0.0
0.0
0.32
649
7054
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
226
1953
1.18
1.51
2.0
2.3
e6/l
0.7
1.1
2.49
123
1013
(4306422)
41
283
1.46
1.50
1.0
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
716
6692
1.11
1.47
4.7
5.2
umol/l
9.3
9.3
0.02
682
6307
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
169
0.47
1.46
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
32
211
1.53
1.46
2.9
3.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
203
1.54
1.46
2.6
2.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
210
2423
0.85
1.44
1.7
1.6
%
1.3
1.3
1.06
185
2202
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
154
0.45
1.43
1.7
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
697
7438
0.90
1.43
5.1
6.1
%
7.7
7.9
1.21
651
7064
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
42
295
1.43
1.42
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
349
3132
1.14
1.42
1.9
2.0
umol/l
2536.0
2530.5
0.00
323
2825
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
40
2.26
1.40
1.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
40
562
0.71
1.39
1.1
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
743
7894
0.90
1.39
4.9
5.9
e9/l
0.5
0.5
3.29
648
7051
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
41
2.20
1.37
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
255
2883
0.87
1.35
1.3
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
104
1272
0.81
1.34
1.5
1.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
39
0.00
1.33
0.0
8.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
21
332
0.63
1.32
1.4
3.0
mg/l
1.1
1.3
0.62
21
314
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1444
14816
0.89
1.32
2.8
3.0
mmol/l
1.2
1.2
0.81
1399
14231
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
120
992
1.22
1.32
1.5
1.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
15
83
1.81
1.31
1.2
3.1
mg/l
147.0
152.3
—
7
53
(3044889) 12 lead EKG panel
964
9187
1.10
1.31
2.5
2.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
696
7402
0.91
1.31
4.9
5.9
%
2.7
2.7
0.01
643
6969
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1705
16766
1.18
1.30
7.7
8.1
u/l
23.8
23.8
0.04
1672
16394
(3019198) Lymphocytes [#/volume] in Blood
775
8197
0.91
1.30
4.8
5.9
e9/l
1.9
2.0
1.49
702
7443
(3044290) Cell count panel - Cerebral spinal fluid
24
366
0.65
1.29
1.7
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
131
0.46
1.28
1.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
89
1100
0.80
1.27
1.7
2.4
ml/min/173m2
79.0
80.2
0.08
25
413
(3022096) Basophils/100 leukocytes in Blood
673
7160
0.91
1.26
4.8
6.0
%
0.7
0.7
0.02
619
6732
(40768804) Tissue Pathology biopsy report
744
7011
1.10
1.26
1.9
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
160
1366
1.19
1.26
1.7
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
95
1164
0.81
1.26
1.7
2.6
g/l
10.2
10.5
0.41
85
1084
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
95
772
1.24
1.23
1.2
1.3
ug/l
2.7
3.2
0.59
89
713
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
85
1.77
1.23
1.3
1.9
%
43.9
36.3
—
7
48
(3021879) Hepatitis B virus core Ab [Presence] in Serum
204
1783
1.16
1.22
1.6
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1622
15906
1.14
1.21
10.6
10.5
%
39.3
39.8
1.80
1380
13620
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
78
1.80
1.21
1.5
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
733
7748
0.91
1.18
4.8
5.9
%
30.1
30.0
0.10
685
7338
(3009508) Creatinine [Moles/volume] in Urine
285
3168
0.88
1.18
3.2
3.1
mmol/l
8.1
7.6
0.69
250
2772
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
116
969
1.21
1.17
1.4
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
141
1.57
1.17
1.4
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1103
10613
1.09
1.16
6.0
6.6
u/l
70.6
71.4
0.36
1039
10087
(3018010) Neutrophils/100 leukocytes in Blood
725
7662
0.91
1.16
4.7
5.7
%
56.9
56.3
0.82
679
7264
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
43
317
1.36
1.15
2.7
1.9
g/l
1.2
1.3
0.30
37
264
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
39
2.06
1.15
1.3
2.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
39
2.06
1.15
1.0
1.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
544
5075
1.10
1.12
4.0
4.6
mmol/l
1.2
1.2
4.35
498
4675
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
30
2.34
1.12
1.1
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
20
306
0.65
1.12
1.3
1.3
nmol/l
1.0
1.5
2.22
15
249
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
416
3831
1.11
1.11
2.1
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
220
2475
0.87
1.11
3.1
3.3
mg/l
84.3
381.0
2.64
141
1504
(3002179) Metamyelocytes/100 leukocytes in Blood
89
1080
0.82
1.10
3.1
4.4
%
0.5
0.7
0.40
16
197
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1509
15404
0.90
1.09
3.1
3.3
mmol/l
1.5
1.6
1.35
1461
14798
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
113
950
1.20
1.08
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
206
0.58
1.08
1.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
7
32
2.19
1.08
1.3
1.8
—
—
—
0
0
(4268621)
13
216
0.60
1.04
2.7
2.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
8
150
0.53
1.03
1.1
1.3
mmol/l
1.9
1.8
—
8
139
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
34
2.06
1.03
1.3
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
34
2.06
1.03
1.3
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
141
1628
0.86
1.02
1.9
2.1
nmol/l
355.9
370.7
0.48
130
1506
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
177
0.56
1.01
1.5
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
53
1.89
1.01
2.6
2.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
59
467
1.27
1.00
1.8
2.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
123
1.55
0.99
1.2
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1175
11386
1.08
0.97
3.5
3.6
mm/h
8.4
9.4
3.39
1123
10760
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
122
1046
1.18
0.96
2.3
2.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
16
100
1.61
0.96
2.1
2.3
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
9
50
1.80
0.96
1.1
1.7
%
—
5.8
—
0
15
(3001019) Free T4 and TSH panel - Serum or Plasma
165
1870
0.87
0.95
1.7
1.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
11
62
1.78
0.94
1.1
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
369
3409
1.10
0.93
3.0
3.1
%
101.1
99.7
0.60
357
3306
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1519
15464
0.91
0.90
3.2
3.3
mmol/l
4.9
4.9
0.49
1471
14894
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
10
170
0.59
0.90
1.3
2.0
nmol/l
20.2
19.5
—
10
164
(3035285) Chloride [Moles/volume] in Venous blood
5
101
0.49
0.89
1.2
2.0
mmol/l
106.2
105.6
—
5
101
(3041354) Potassium [Moles/volume] in Venous blood
5
101
0.49
0.89
1.2
2.0
mmol/l
3.7
3.9
—
5
101
(3017181) Myelocytes/100 leukocytes in Blood
99
1160
0.85
0.88
3.5
4.6
%
1.0
0.9
0.13
20
269
(3025018) Bordetella pertussis Ab [Titer] in Serum
18
119
1.52
0.88
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
40
516
0.77
0.88
2.6
2.5
ng/l
97.7
72.5
0.35
29
454
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
30
2.00
0.87
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
105
899
1.18
0.86
3.6
3.7
ug/l
28.9
48.6
0.18
62
640
(3024891) Influenza virus A+B Ag [Presence] in Specimen
41
526
0.77
0.86
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
232
2556
0.89
0.86
3.7
4.0
mg/mmol
15.1
10.2
0.52
157
1620
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
558
5271
1.08
0.86
3.0
3.0
u/l
25.4
28.3
1.92
539
5042
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
175
1558
1.14
0.86
2.7
2.2
umol/l
4.4
5.2
0.62
152
1302
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
12
192
0.62
0.86
1.6
1.2
umol/l
5.5
5.4
0.07
12
181
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
33
434
0.76
0.84
1.2
1.3
mg/l
465.5
452.9
0.05
33
411
(3042936) Bacteria identified in Isolate by Culture
187
1676
1.13
0.83
1.8
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
137
0.58
0.83
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
137
0.58
0.83
1.3
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
111
0.54
0.83
1.5
1.2
—
50.8
—
0
13
(3038026) Centromere Ab [Units/volume] in Serum
6
112
0.53
0.83
1.5
1.2
—
49.4
—
0
12
(3038177) Helicobacter pylori Ab [Presence] in Serum
47
373
1.27
0.81
1.1
1.1
—
—
—
0
0
(44790047)
19
130
1.47
0.81
1.6
1.5
—
—
—
0
0
(44790048)
19
130
1.47
0.81
1.6
1.5
—
—
—
0
0
(44790049)
19
130
1.47
0.81
1.6
1.5
—
—
—
0
0
(44806118)
19
130
1.47
0.81
1.6
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
363
0.74
0.80
1.4
1.3
ug/g
261.8
311.4
0.43
13
185
(3020961) Endomysium IgA Ab [Titer] in Serum
122
1065
1.16
0.80
1.2
1.1
titre
658.0
119.3
—
5
29
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
2.1
—
415793.9
—
0
19
(3051651) Icteric interference index of Serum or Plasma
11
66
1.67
0.78
1.5
2.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
13
199
0.65
0.78
1.0
1.1
mg/l
206.2
223.1
0.19
13
170
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
96
0.52
0.78
1.0
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
96
1113
0.86
0.78
3.6
4.7
%
0.2
0.2
0.05
19
246
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
97
0.51
0.78
1.2
2.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
123
0.57
0.78
1.0
2.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
125
0.56
0.77
1.4
1.2
u/l
9.2
20.6
—
7
103
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
20
140
1.43
0.77
2.9
3.9
u/ml
66.7
317.0
0.94
20
133
(40761535) Cells panel - Urine sediment
104
901
1.16
0.76
2.9
3.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
22
157
1.41
0.76
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
107
1.50
0.76
1.4
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
67
559
1.21
0.76
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
197
0.66
0.75
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
42
333
1.27
0.75
1.1
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
266
0.71
0.74
1.1
1.8
g/l
6.8
7.2
0.66
14
215
(3023420) DNA double strand Ab [Units/volume] in Serum
16
231
0.69
0.73
1.1
1.8
—
46.5
—
0
13
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
19
133
1.43
0.73
1.1
1.0
iu/ml
8.9
7.4
—
8
41
(3025159) Blasts/100 leukocytes in Blood
93
1074
0.86
0.73
3.6
4.6
%
0.0
0.4
0.59
19
205
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
265
0.71
0.72
1.1
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
265
0.71
0.72
1.1
1.8
g/l
3.5
3.7
0.68
14
199
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
373
3492
1.08
0.72
1.6
1.6
mmol/l
1.3
1.3
0.38
327
3092
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
25
333
0.75
0.72
1.4
1.6
—
5.0
—
0
8
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
6
110
0.54
0.72
1.5
1.2
—
60.1
—
0
8
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1533
15561
0.92
0.71
3.3
3.5
mmol/l
3.0
2.9
0.12
1472
14868
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
75
637
1.18
0.71
1.4
1.4
u/l
25.7
23.1
0.26
63
536
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
19
134
1.42
0.71
1.1
1.1
ratio
1.1
1.0
—
8
53
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
9
57
1.58
0.71
1.1
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
161
1786
0.89
0.70
2.9
3.2
mmol/l
0.8
0.8
1.08
151
1682
(3003327) Ova and parasites identified in Stool by Light microscopy
64
759
0.84
0.70
1.6
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
146
0.61
0.69
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
251
2315
1.10
0.69
1.5
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
52
428
1.22
0.69
2.2
2.5
%
13.3
13.1
0.46
52
423
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
27
1.85
0.68
5.4
9.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
11
69
1.60
0.68
2.5
2.1
mg/l
11.5
10.1
0.30
11
57
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
118
0.59
0.68
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
397
4211
0.93
0.67
3.2
4.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
14
94
1.49
0.66
2.2
2.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
13
190
0.68
0.65
1.2
2.4
kpa
8.3
8.8
0.34
13
178
(3001556) Androgen free Index in Serum or Plasma
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
258
0.73
0.63
1.1
1.8
g/l
2.8
3.0
0.52
14
206
(3006184) Hemoglobin [Mass/volume] in Capillary blood
15
212
0.71
0.63
1.7
1.8
g/l
130.5
130.9
—
10
157
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
79
1.52
0.62
1.2
1.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
34
270
1.26
0.62
1.4
1.6
g/l
0.6
0.7
0.11
24
198
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
103
0.58
0.62
2.8
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
66
770
0.85
0.61
2.3
3.6
mmol/l
1.3
1.7
0.46
53
613
(3029075) Extractable nuclear Ab panel - Serum
8
50
1.60
0.61
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
73
629
1.17
0.61
1.3
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
13
88
1.48
0.60
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
56
661
0.84
0.60
2.3
2.1
u/l
35.5
39.8
1.19
50
616
(44816559) Phosphatidylethanol [Mass/volume] in Blood
30
378
0.79
0.60
1.2
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
50
418
1.20
0.59
1.7
1.9
—
—
—
0
0
(4027681)
11
162
0.68
0.58
1.1
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
235
2529
0.92
0.58
1.4
1.4
nmol/l
21.5
20.9
0.30
211
2293
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
89
1.46
0.58
1.1
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
13
89
1.46
0.58
2.6
2.3
ug/l
1399.6
104.6
0.43
13
83
(3011412) CD3 cells [#/volume] in Blood
11
161
0.68
0.57
1.4
2.9
e9/l
1.8
1.2
—
5
94
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
81
1.48
0.57
1.8
2.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
598
5744
1.06
0.57
4.6
5.4
mmol/l
1.2
1.2
4.29
506
4884
(3021447) Carbon dioxide [Partial pressure] in Venous blood
67
774
0.86
0.56
2.3
3.6
kpa
5.5
5.8
1.77
67
748
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
185
2009
0.91
0.56
2.2
2.4
mmol/l
2.4
2.4
0.01
163
1776
(3021901) Oxygen saturation in Capillary blood
10
149
0.67
0.56
1.1
2.3
—
—
—
0
0
(4010399)
77
880
0.87
0.56
1.3
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
89
0.56
0.56
1.4
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
153
1675
0.91
0.55
1.6
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
65
1.54
0.55
1.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
78
889
0.87
0.55
1.4
1.9
g/l
1.3
1.3
0.13
71
828
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
31
384
0.80
0.55
1.2
1.3
mmol/l
3.3
3.5
1.20
31
355
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
122
0.65
0.54
1.8
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
169
1551
1.10
0.54
1.1
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
60
1.50
0.54
1.1
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
159
1734
0.91
0.54
1.5
1.6
nmol/l
1184.4
1185.4
0.00
131
1378
(3027945) Reticulocytes/100 erythrocytes in Blood
84
948
0.88
0.52
2.8
2.5
%
1.6
1.7
0.58
77
832
(3009343) pH of Capillary blood
44
521
0.84
0.51
1.6
2.7
ph
7.4
7.4
—
5
72
(3004588) Protein electrophoresis panel - Serum or Plasma
39
467
0.83
0.51
1.1
1.9
—
—
—
0
0
(4034850)
38
456
0.83
0.51
6.8
7.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
292
0.79
0.51
1.2
1.4
—
—
—
0
0
(1002224) Polysomnography panel
78
881
0.88
0.50
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
33
270
1.23
0.50
1.1
1.1
—
—
—
0
0
(4094501)
30
243
1.24
0.49
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
178
0.73
0.48
1.7
2.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
189
0.74
0.48
2.1
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
111
0.63
0.48
2.0
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
11
76
1.45
0.48
1.2
1.8
u/field
2.0
2.5
—
5
41
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
43
506
0.85
0.48
1.6
2.6
mmol/l
1.3
1.1
0.27
28
359
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
7
47
1.49
0.47
1.0
1.0
ug/l
89.6
74.7
—
7
42
(3027944) Amphetamines [Presence] in Urine
104
1149
0.90
0.47
2.4
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
15
199
0.75
0.46
1.1
1.3
—
37.0
—
0
5
(40758558) Short blood count panel - Blood
402
3841
1.06
0.46
4.1
6.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
31
375
0.82
0.46
1.6
1.3
e6/l
8.9
24.1
0.91
26
285
(3024354) Oxygen [Partial pressure] in Venous blood
53
611
0.86
0.46
2.2
2.9
kpa
4.8
4.7
0.16
53
589
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
118
1293
0.91
0.46
4.5
4.4
—
—
—
0
0
(4133840)
7
49
1.43
0.46
1.1
1.2
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
11
153
0.72
0.45
1.1
1.7
mu/l
446.9
482.5
0.08
11
145
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
31
374
0.83
0.45
1.6
1.4
e6/l
236.9
10665.6
0.54
26
300
(3004789) Transferrin [Mass/volume] in Serum or Plasma
190
1771
1.08
0.45
2.0
2.3
g/l
2.5
2.5
0.58
172
1659
(3014148) Varicella zoster virus Ab [Titer] in Serum
39
330
1.19
0.44
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
212
1989
1.07
0.43
2.1
2.3
umol/l
14.4
14.6
0.21
189
1871
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
43
500
0.86
0.43
1.3
1.3
u/ml
1.9
10.8
—
6
88
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
91
0.66
0.42
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
91
0.66
0.42
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1520
15034
1.06
0.42
12.0
12.2
g/l
332.0
331.8
0.54
1507
14901
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
57
1.41
0.42
1.3
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
62
548
1.14
0.41
1.5
1.6
iu/ml
0.1
0.3
—
10
95
(1616796) Gas panel - Central venous blood
16
206
0.77
0.41
1.3
2.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
150
0.73
0.41
1.0
1.4
g/l
0.8
0.9
1.05
11
150
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.2
—
0
8
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.8
—
21.5
—
0
15
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
16
0.00
0.41
0.0
2.1
—
0.9
—
0
16
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
161
0.74
0.41
1.3
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
88
971
0.90
0.40
1.9
1.7
mg/l
3.2
4.1
0.51
63
664
(3048879) Bone marrow aspiration report
0
17
0.00
0.40
0.0
3.6
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
2.3
—
0
17
(3003740) Influenza virus B Ag [Presence] in Specimen
40
465
0.86
0.40
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
60
1.33
0.40
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
40
464
0.86
0.39
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
97
1.34
0.39
1.0
1.1
miu/ml
1300.8
1498.2
0.25
13
97
(3027008) Opiates [Presence] in Urine
106
1156
0.91
0.39
2.6
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
71
636
1.12
0.39
1.4
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
182
0.77
0.39
2.1
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
242
1.20
0.39
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
159
0.75
0.38
1.4
1.5
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
36
1.39
0.38
1.0
4.8
mg/l
39.6
68.7
—
5
24
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
184
1728
1.07
0.38
1.8
2.5
ng/l
327.5
430.9
0.46
150
1388
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
468
4518
1.05
0.38
1.3
1.3
u/ml
1.3
1.5
0.19
129
1315
(3028300) Cannabinoids [Presence] in Urine
107
1163
0.92
0.37
2.6
1.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
115
0.69
0.37
1.1
1.4
promille
1.7
1.0
—
8
93
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
32
375
0.85
0.36
1.1
1.3
—
0.4
—
0
7
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
53
597
0.88
0.36
1.6
2.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
71
1.27
0.36
2.0
2.1
umol/l
29.1
29.4
—
9
65
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
144
1.25
0.35
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
144
1.25
0.35
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
144
1.25
0.35
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
43
1.40
0.35
1.2
1.9
ug/l
15.7
20.9
—
6
43
(3000764) Benzodiazepines [Presence] in Urine
106
1147
0.92
0.34
2.6
1.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
43
489
0.88
0.34
1.3
1.3
u/ml
1.2
11.8
—
5
57
(3004616) Nuclear Ab [Presence] in Serum
16
199
0.80
0.33
1.8
1.3
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
12
155
0.77
0.33
1.2
1.7
%
67.0
71.2
0.36
12
147
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
89
0.67
0.33
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
332
3451
0.95
0.32
2.6
3.5
ph
7.4
7.4
0.24
62
646
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
33
285
1.16
0.32
3.7
3.2
u/ml
104.5
103.2
0.01
28
246
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
11
83
1.33
0.32
1.2
1.6
%
161.3
137.4
0.26
11
78
(3016879) Cocaine [Presence] in Urine
97
1048
0.92
0.31
2.7
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1468
14542
1.04
0.31
3.1
3.3
mmol/l
5.5
5.6
1.38
1408
13811
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
53
1.32
0.30
1.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
147
1.23
0.30
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
147
1.23
0.30
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
147
1.23
0.30
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
58
641
0.90
0.30
4.3
2.6
e9/l
63.5
73.2
0.88
39
462
(3015076) Soybean IgE Ab [Units/volume] in Serum
21
175
1.20
0.30
1.0
1.0
—
0.2
—
0
25
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
163
0.80
0.29
1.6
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
107
0.75
0.29
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
108
0.74
0.29
1.0
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
29
334
0.87
0.28
1.3
1.3
nmol/l
24.5
33.6
1.51
24
306
(3015377) Calcium [Moles/volume] in Serum or Plasma
417
4298
0.96
0.28
2.5
3.2
mmol/l
2.3
2.3
0.00
382
3946
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
15
121
1.24
0.28
1.3
3.2
nmol/l
4.7
2.9
0.30
15
114
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
174
1654
1.06
0.27
1.3
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
37
417
0.89
0.27
2.1
1.7
—
462.4
—
0
17
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1183
11971
0.97
0.27
2.8
2.7
u/l
32.9
32.4
0.04
1142
11576
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
79
852
0.92
0.26
2.5
2.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
528
5153
1.03
0.26
4.0
4.2
g/l
36.6
37.1
1.23
493
4842
(3035637) Corticotropin [Mass/volume] in Plasma
16
192
0.83
0.25
1.4
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
38
339
1.12
0.25
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
497
4849
1.03
0.25
1.6
1.8
pmol/l
98.3
100.1
0.38
269
2673
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
549
0.91
0.25
2.2
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
105
1.24
0.24
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
54
493
1.10
0.24
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
116
1228
0.94
0.24
2.5
2.3
e9/l
4.1
4.1
0.07
100
1043
(3014765) Yersinia sp identified in Stool by Organism specific culture
54
494
1.10
0.24
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
85
0.70
0.24
1.8
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
28
246
1.14
0.23
1.3
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
45
495
0.91
0.23
1.0
1.1
u/ml
0.4
0.9
0.89
13
210
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
75
698
1.08
0.23
1.5
1.4
nmol/l
0.6
0.5
0.23
66
570
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
190
1.16
0.23
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
48
525
0.91
0.22
1.0
1.1
u/ml
10.1
5.2
0.38
17
277
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
36
400
0.90
0.22
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
54
496
1.09
0.22
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
358
0.89
0.22
1.6
2.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
167
0.84
0.21
1.1
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
19
163
1.17
0.21
1.3
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
8.8
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
1.4
—
0
6
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.1
—
13.2
—
0
10
(3009677) Dengue virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.6
—
39.8
—
0
10
(1001926) Buprenorphine [Presence] in Urine by Screen method
80
853
0.94
0.21
3.0
2.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
12
0.00
0.21
0.0
3.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.2
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
84
790
1.07
0.20
1.6
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
115
0.78
0.20
1.2
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
51
1.18
0.19
1.7
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
186
0.86
0.19
1.3
2.0
%
17.8
16.8
—
5
97
(3024139) IgG subclass 3 [Mass/volume] in Serum
21
184
1.14
0.19
1.3
1.4
g/l
0.4
0.4
0.12
11
125
(3028192) IgG subclass 2 [Mass/volume] in Serum
21
184
1.14
0.19
1.3
1.4
g/l
3.4
3.0
0.38
11
125
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
30
332
0.90
0.18
3.0
3.7
%
56.0
56.5
0.10
30
332
(3027135) IgG subclass 1 [Mass/volume] in Serum
21
185
1.14
0.18
1.3
1.4
g/l
6.7
6.4
0.10
11
126
(4062490)
21
185
1.14
0.18
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
216
0.88
0.17
1.1
1.3
—
—
—
0
0
(3000492) Spirometry study
177
1709
1.04
0.17
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
163
0.86
0.17
1.1
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
44
475
0.92
0.17
4.5
2.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
63
1.11
0.17
2.4
1.9
—
2.1
—
0
7
(3019225) pH of Specimen
107
1022
1.05
0.17
2.0
3.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
83
787
1.06
0.17
1.2
1.3
u/l
12.1
11.2
0.24
73
632
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
67
0.75
0.17
2.0
2.1
umol/l
48.8
53.8
—
5
59
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
80
758
1.06
0.16
1.4
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
311
1.09
0.16
1.1
1.2
u/ml
1.3
3.0
—
8
114
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
14
120
1.17
0.16
1.5
1.4
umol/l
10.6
9.1
0.62
14
111
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
70
1.14
0.16
3.1
2.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
27
244
1.11
0.16
1.4
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
162
0.86
0.16
1.1
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
131
1260
1.04
0.16
1.5
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
119
1239
0.96
0.16
1.4
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
270
2634
1.03
0.15
1.4
1.4
titre
291.4
617.1
6.03
49
523
(3006653) Thiamine [Moles/volume] in Blood
6
78
0.77
0.15
2.3
1.7
nmol/l
126.1
131.2
—
6
78
(3021589) Normoblasts [#/volume] in Blood
688
6792
1.02
0.15
7.4
7.7
e9/l
0.0
0.0
0.29
553
5581
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
165
1597
1.04
0.15
2.1
2.4
%
23.9
24.2
0.10
140
1394
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
182
0.88
0.15
2.9
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
52
554
0.94
0.15
1.3
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
80
1.13
0.15
1.0
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
141
1361
1.04
0.15
2.5
2.2
u/l
38.5
34.3
0.19
120
1157
(3011288) Drugs identified in Urine by Screen method
75
789
0.95
0.15
3.8
2.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
9
82
1.10
0.15
1.0
2.6
nmol/l
54.4
63.0
—
9
82
(3015171) Extractable nuclear Ab [Units/volume] in Serum
77
809
0.95
0.15
1.3
1.3
u/ml
0.3
1.3
—
10
70
(3030905) Polymorphonuclear cells [#/volume] in Blood
30
327
0.92
0.14
3.0
3.5
e9/l
4.0
3.9
0.14
30
327
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
86
0.81
0.14
1.0
1.0
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
7
86
0.81
0.14
7.1
7.4
mg/l
11.3
10.7
—
7
81
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
34
368
0.92
0.14
1.1
1.2
u/ml
187.7
264.6
2.12
24
255
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
131
1.15
0.14
1.9
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
25
274
0.91
0.13
2.6
2.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
55
582
0.94
0.13
1.0
1.1
u/ml
2.0
0.9
0.44
15
219
(3026389) Candida sp identified in Specimen by Organism specific culture
27
247
1.09
0.13
1.0
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
151
1.13
0.13
1.4
1.2
u/ml
0.2
0.3
—
8
56
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
159
0.88
0.13
1.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
159
0.88
0.13
1.1
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
159
0.88
0.13
1.1
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
32
296
1.08
0.13
1.2
1.3
u/ml
3.3
3.3
—
10
123
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
211
0.90
0.13
1.1
2.6
—
369.1
—
0
12
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
117
0.85
0.13
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
113
1171
0.96
0.13
1.3
1.3
au/ml
33.0
32.8
—
10
39
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
26
238
1.09
0.13
1.5
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
109
0.82
0.13
1.0
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
15
169
0.89
0.12
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
127
0.87
0.12
1.0
3.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
109
1052
1.04
0.12
1.4
1.3
miu/ml
212.8
242.3
0.43
60
546
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
15
168
0.89
0.11
1.8
3.8
u/ml
32.4
42.4
0.27
15
168
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
117
1207
0.97
0.11
1.0
1.0
—
—
—
0
0
(4198724)
12
105
1.14
0.11
1.1
3.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
115
0.87
0.10
1.3
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
42
444
0.94
0.10
1.0
1.1
u/ml
1.5
4.4
0.69
13
155
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
329
1.07
0.10
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
263
2584
1.02
0.10
2.4
2.4
ug/g
92.5
96.0
0.07
216
2009
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
125
1.12
0.10
1.2
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
112
1088
1.03
0.10
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
135
1.11
0.09
1.1
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
15
135
1.11
0.09
1.1
2.6
%
63.5
64.3
0.05
15
135
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
5
46
1.09
0.09
4.4
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
114
0.88
0.09
1.9
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
16
176
0.91
0.09
1.7
1.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
27
252
1.07
0.09
1.1
1.1
iu/ml
2.7
1154.9
—
7
70
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
48
1.04
0.09
2.2
1.7
ug/l
7.1
7.9
—
5
48
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
55
1.09
0.09
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
55
1.09
0.09
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
55
1.09
0.09
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
37
390
0.95
0.08
1.1
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
23
247
0.93
0.08
2.9
4.5
u/ml
44.1
83.1
0.59
11
74
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
56
1.07
0.08
1.3
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
61
0.82
0.08
1.6
1.2
u/l
8.2
17.2
—
5
56
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
1.0
1.9
—
—
—
0
0
(4146454)
7
65
1.08
0.08
2.6
2.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
205
1.07
0.08
1.1
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
74
1.08
0.07
1.4
1.7
—
2275925.7
—
0
7
(3000991) Gas panel - Venous blood
72
698
1.03
0.07
7.9
7.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
125
1223
1.02
0.07
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
72
742
0.97
0.07
1.8
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
82
0.85
0.07
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1298
13024
0.99
0.07
3.6
3.9
mmol/mol
36.7
37.2
1.82
1245
12444
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
89
1.12
0.07
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
89
1.12
0.07
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
89
1.12
0.07
1.2
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
89
1.12
0.07
1.2
3.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
133
1356
0.98
0.06
1.3
1.7
mu/l
263.1
334.1
1.80
117
1205
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
92
0.87
0.06
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
155
1523
1.02
0.06
1.3
1.3
—
—
—
0
0
(3013512) EKG study
283
2863
0.99
0.06
2.4
2.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
885
8892
0.99
0.06
6.5
9.1
e9/l
4.0
3.9
0.05
772
7900
(1761868) Lipid panel - Serum or Plasma
693
6891
1.01
0.06
2.1
2.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
31
296
1.05
0.06
1.5
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
139
1.08
0.05
1.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
216
2186
0.99
0.05
1.3
1.3
iu/l
26.6
25.9
0.11
188
1881
(40768797) Stomach Pathology biopsy report
186
1884
0.99
0.05
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
222
0.95
0.05
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
222
0.95
0.05
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
31
297
1.04
0.05
3.1
4.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
252
0.95
0.05
2.8
3.0
mg/l
15.1
20.2
0.60
13
156
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
88
897
0.98
0.04
2.1
3.1
mmol/l
1.2
1.2
0.51
78
789
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
150
0.93
0.04
2.9
2.8
—
—
—
0
0
(44813793)
14
150
0.93
0.04
1.0
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
10
109
0.92
0.04
1.8
1.5
mosm/kgh2o
279.9
286.4
—
10
91
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
52
507
1.03
0.04
1.9
2.0
ug/l
3.8
5.1
0.59
43
444
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
136
1344
1.01
0.03
2.9
3.2
%
32.9
32.4
0.18
106
1032
(3013005) Retinol [Moles/volume] in Serum or Plasma
10
92
1.09
0.03
2.3
2.1
umol/l
2.0
1.9
—
10
85
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
138
0.94
0.02
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
17
178
0.95
0.02
1.4
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
41
401
1.02
0.02
1.0
1.1
u/ml
7.5
3.7
0.36
14
158
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
238
0.97
0.02
1.4
1.5
—
—
—
0
0
(4035726)
106
1050
1.01
0.02
1.3
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
69
699
0.99
0.01
1.1
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
127
0.94
0.01
4.3
7.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
137
0.95
0.01
1.5
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
187
0.96
0.01
1.8
3.4
u/ml
0.2
0.4
—
9
93
(42870588) Differential panel, method unspecified - Blood
480
4812
1.00
0.01
4.9
6.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
176
0.97
0.00
1.9
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
19
184
1.03
0.00
1.1
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
44
434
1.01
0.00
10.8
8.1
mmol/l
24.1
24.1
0.01
44
412
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1451
14516
1.00
0.00
7.1
7.9
ml/min/173m2
95.2
93.5
3.33
1216
11866
(3020717) Zinc [Moles/volume] in Serum or Plasma
13
125
1.04
0.00
1.9
1.6
umol/l
44.8
22.8
1.22
13
119
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
135
1.04
0.00
1.8
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
52
525
0.99
0.00
1.3
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
94
945
0.99
0.00
4.0
9.8
inr
1.0
1.1
—
10
169
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
126
1265
1.00
0.00
2.3
2.3
au/ml
19.8
26.6
0.51
13
103
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
106
1.04
0.00
1.3
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
126
1.03
0.00
1.1
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
61
606
1.01
0.00
1.7
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
257
2566
1.00
0.00
1.5
1.5
pmol/l
62553606.1
35284268.2
0.25
235
2290
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
152
0.99
0.00
2.0
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
20
202
0.99
0.00
1.2
2.5
mmol/l
1.4
2.5
—
10
129
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
118
1.02
0.00
1.1
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
178
1.01
0.00
1.4
2.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
127
1.02
0.00
2.0
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
14
137
1.02
0.00
1.6
2.2
u/ml
4.2
4.1
—
9
119
(3010726) Horse dander IgE Ab [Units/volume] in Serum
51
507
1.01
0.00
1.0
1.1
u/ml
3.9
1.3
—
10
109
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
196
1957
1.00
0.00
1.2
1.2
iu/ml
144.5
156.1
0.15
75
801
(3007164) IgA [Mass/volume] in Serum or Plasma
388
3875
1.00
0.00
1.3
1.4
g/l
2.1
2.1
0.25
235
2552
(3007733) Chloride [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
76.8
—
0
5
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
171.6
—
0
5
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
26.0
—
0
5
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
91
0.99
0.00
1.2
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
81
0.99
0.00
1.0
1.1
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.3
—
7.9
—
0
6
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4281824)
21
210
1.00
0.00
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
1.3
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
130
1.00
0.00
1.3
1.4
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.3
—
2.2
—
0
6
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
74
0.95
0.00
1.6
2.0
—
—
—
0
0
(4212803)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
66
0.91
0.00
3.2
1.2
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
68
0.88
0.00
1.3
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
50
1.00
0.00
1.0
2.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
63
0.95
0.00
4.3
4.7
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
252.8
—
0
6
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
6
0.00
0.00
0.0
1.3
—
24.2
—
0
6
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
1.4
—
39.6
—
0
9
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
-0.00
0.0
1.2
—
1.6
—
0
9
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
9
0.00
-0.00
0.0
1.1
—
9.0
—
0
9
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint O15_PLAC_PRAEVIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| O15_PLAC_PRAEVIA | 0.484 [0.36, 0.65] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.247 |
During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 10191 females with O15_PLAC_PRAEVIA died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have O15_PLAC_PRAEVIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.045% | No data |
| 5 | 0.269% | No data |
| 10 | 0.725% | No data |
| 15 | 1.438% | No data |
| 20 | 2.38% | No data |
Relationships between endpoints
↥Index endpoint: O15_PLAC_PRAEVIA – Placenta praevia
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data